The Asco Post featured ITM investigator Mark Ratain, MD, who weighed in on the benefits of seamless trials for testing new drugs. Seamless trials – as opposed to trials split into distinct phases of testing – pose the opportunity for more efficient and effective studies.

“A lot of impetus for this meeting is to say how we can get rid of waste.”

-Mark Ratain, MD, Leon O. Jacobson Professor of Medicine, Director of the Center for Personalized Therapeutics, and Associate Director for Clinical Sciences at the Comprehensive Cancer Center

Click Here to Read More

Source: The Asco Post